ArticlebioRxiv : the preprint server for biology2025

Sensitizing Immune-Refractory Ovarian Tumors via p53 Mutation-Tailored Immunotherapy.

Rishita Chatterjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.